Zephyrus Biosciences Company
%20.jpg)
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Investors
%20.jpg)
.png)
(INV)%20.jpg)
Funding Status:
M&A
Headquarters:
Berkeley, California, United States
Founded Date:
2013-01-01
Employee Number:
1-10
Last Funding Type:
Seed
Total Funding:
$1.9M
Industry:
Biotechnology, Hardware, Health Care
Investors Number:
10
Technology:
Regenerative Medicine
Investor Type:
For Profit
Number Of Exists:
Seed